![](https://news.europawire.eu/wp-content/uploads/2018/04/Chinese-Patent-Office-issued-patent-for-Merck’s-CRISPR-technology-used-in-a-genomic-integration-method-for-eukaryotic-cells-144x144.jpg)
Merck today (23 APR 2018) announced that the Chinese Patent Office has issued a notice granting Merck’s patent application for the company’s CRISPR technology used in a genomic-integration method for eukaryotic cells. Patent in China covers integration of an external … Read the full press release